PEEK

Americhem Launches New EcoLube™ Line of PFAS-Free Internally Lubricated Compounds

Retrieved on: 
星期四, 六月 13, 2024

Americhem, Inc., a globally recognized designer and manufacturer of custom color masterbatch, functional additives, engineered compounds, and performance technologies, has launched the EcoLube™ line of PFAS-free internally lubricated compounds.

Key Points: 
  • Americhem, Inc., a globally recognized designer and manufacturer of custom color masterbatch, functional additives, engineered compounds, and performance technologies, has launched the EcoLube™ line of PFAS-free internally lubricated compounds.
  • Americhem has formulated EcoLube™ compounds in a wide variety of base resins that include ABS, PBT, PCABS, PC, PEI, PPE, PPS, PE, PP, PSU, PPSU, POM, PEEK, PPA, PA, and TPU.
  • This new line is just one example of how Americhem aims to become a global sustainability leader in the polymers industry.
  • For any questions regarding EcoLube™ compounds, please contact Matt Miklos at [email protected] .

PEEK WEALTH is proud to announce the newest addition to its financial team, Brett Elliott, formally of Edward Jones

Retrieved on: 
星期四, 五月 9, 2024

He later became a financial advisor in 2020 with Edward Jones and managed wealth for executives, business owners and individuals.

Key Points: 
  • He later became a financial advisor in 2020 with Edward Jones and managed wealth for executives, business owners and individuals.
  • It was at Edward Jones where Mr. Elliott established a relationship with Justin Peek, CEO and Founder of PEEK WEALTH.
  • “I'm pleased to welcome Brett to the PEEK WEALTH family,” says Justin Peek, “he brings valuable insight and experience to the table.
  • As a financial advisor with PEEK WEALTH, Brett Elliott will continue to work with individuals to help them pursue their financial goals.

Anika Reports First Quarter 2024 Financial Results

Retrieved on: 
星期三, 五月 8, 2024

BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2024.

Key Points: 
  • Revenue up 7% on growing demand and favorable order timing; On-track for 2024 revenue guidance
    Cost reduction initiatives complete; On-track to achieve 2024 adjusted EBITDA guidance of $25-30 million, up over 75% at the midpoint
    BEDFORD, Mass., May 08, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its first quarter ended March 31, 2024.
  • Revenue in the first quarter of 2024 was $40.5 million, up 7% compared to $37.9 million in the first quarter of 2023.
  • As such, Anika expects revenue for fiscal year 2024 of $168 to $173 million, representing growth of 1% to 4% compared to 2023.
  • Anika’s management will hold a conference call and webcast to discuss its financial results and business highlights today, Wednesday, May 8, 2024, at 5:30 pm ET.

3D Systems Announces FDA Clearance for World’s First 3D-Printed PEEK Cranial Implants

Retrieved on: 
星期一, 四月 15, 2024

VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP ® i4 3DF PEEK (polyetheretherketone), and a pre-defined production process.

Key Points: 
  • VSP PEEK Cranial Implant includes a complete FDA-cleared workflow comprising segmentation and 3D modeling software, the 3D Systems EXT 220 MED 3D printer, Evonik VESTAKEEP ® i4 3DF PEEK (polyetheretherketone), and a pre-defined production process.
  • “Receiving FDA clearance for our VSP PEEK Cranial Implant solution is a significant milestone in our journey.
  • With this FDA clearance, we are now able to bring VSP PEEK Cranial Implant to the U.S. — setting a new standard of excellence for these procedures.
  • This FDA clearance enables 3D Systems to significantly expand its PEEK product portfolio through the EXT 220 MED platform.

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Retrieved on: 
星期三, 三月 13, 2024

BEDFORD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Revenue in the fourth quarter of 2023 was $43.0 million, up 8% compared to $39.6 million in the fourth quarter of 2022.
  • Adjusted EBITDA1 was $5.8 million, compared to $1.4 million in the fourth quarter of 2022.
  • “We are pleased to report strong fourth quarter and full year results, including a record year in OA Pain Management.
  • In 2023, Anika launched multiple meaningful new products and made considerable progress addressing the new MDR regulatory requirements in Europe.

Vance Street's Wytech Strengthens Precision Grinding Capabilities with Silvertip Acquisition

Retrieved on: 
星期三, 四月 3, 2024

These companies seek supply chain partners knowledgeable in materials and processes who can engineer solutions to improve their internal production efficiencies.

Key Points: 
  • These companies seek supply chain partners knowledgeable in materials and processes who can engineer solutions to improve their internal production efficiencies.
  • Silvertip expands Wytech and Mountain Manufacturing's capability for new ground mandrels and ensures fast response to the market's R&D needs," said Michael Janish, Managing Partner at Vance Street Capital.
  • Silvertip and Dale Peterson's team have also demonstrated unique know-how for grinding advanced materials, complementing Mountain Manufacturing and Wytech's expertise in stainless and Nitinol grinding.
  • We are very excited to leverage this partnership with Silvertip to expand our FastLane material store and offer these advanced materials by Q3," said Tom Berg, President of Mountain Manufacturing.

DRAKE AND DEMGY FORM TRANS-ATLANTIC ALLIANCE IN HIGH-PERFORMANCE POLYMER SOLUTIONS

Retrieved on: 
星期四, 三月 21, 2024

The Liberty Alliance opens our mutual products and services to customers in France, and to international customers.

Key Points: 
  • The Liberty Alliance opens our mutual products and services to customers in France, and to international customers.
  • Designated the "Liberty Alliance," the partnership draws its name from the close historic ties between the two countries.
  • DRAKE and DEMGY are leaders in high-performance polymer solutions in their regions.
  • DEMGY will also offer turnkey solutions in these materials for mutual customers.

Strong Fourth Quarter Powers 2023 Kelyniam Financials

Retrieved on: 
星期日, 三月 17, 2024

CANTON, Conn., March 17, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2023.

Key Points: 
  • CANTON, Conn., March 17, 2024 /PRNewswire/ -- Kelyniam Global (OTC:KLYG), a maker of custom cranial implants, today announced results for its year ended December 31, 2023.
  • "The company set a quarterly unit sales record in the fourth quarter which contributed to achieving slight unit volume growth over 2022," said Ross Bjella, Kelyniam's CEO.
  • Events that significantly affected the year and 4th quarter included:
    Unit growth was up 40% over the previous quarter.
  • Together with the OsteoStripä and Osteoplugä product lines from Osteopore, Kelyniam is well positioned to become the leader in regenerative options for U.S.

3D Printing High-Performance Plastics Market to Reach $520.0 Million by 2028: BCC Research

Retrieved on: 
星期五, 三月 8, 2024

BOSTON, March 8, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for Global 3D Printing High-Performance Plastics Market is estimated to increase from $163.6 million in 2022 to reach $520.0 million by 2028, at a compound annual growth rate (CAGR) of 21.4% from 2022 through 2028."

Key Points: 
  • BOSTON, March 8, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for Global 3D Printing High-Performance Plastics Market is estimated to increase from $163.6 million in 2022 to reach $520.0 million by 2028, at a compound annual growth rate (CAGR) of 21.4% from 2022 through 2028."
  • This comprehensive report focuses specifically on high-performance plastics within the expansive 3D printing industry, highlighting key materials such as polyamide, polyetherimide, polyetheretherketone, polyetherketoneketone, polyvinylidene difluoride, and polyphenylsulfone.
  • The forecasted revenue projections from 2022 to 2028 encompass each type, technology, end-user, and regional segment, offering a comprehensive outlook on the evolving landscape of the 3D printing high-performance plastics market.
  • The intersection of digitalization, robotics, and the growing demand for personalized, point-of-care medical solutions is fueling a surge in high-performance plastics (HPP) adoption in 3D printing.

MCRA Assists Curiteva Inc. with FDA 510(k) Clearance for Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System

Retrieved on: 
星期二, 二月 20, 2024

MCRA aids Curiteva with 510(k) clearance from FDA for Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System.

Key Points: 
  • MCRA aids Curiteva with 510(k) clearance from FDA for Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System.
  • Curiteva partnered with MCRA previously on Inspire Trabecular PEEK Cervical Interbody Fusion System in February 2023, which also received FDA clearance.
  • MCRA's Spine Regulatory team engaged with Curiteva for the Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System for use in anterior, transforaminal, posterior, and lateral lumbar interbody fusion procedures.
  • Justin Eggleton, Vice President, Head of Musculoskeletal Regulatory Affairs at MCRA, said "MCRA is honored to have collaborated on the pioneering project of Curiteva's Inspire 3D Printed Trabecular PEEK Lumbar Interbody Fusion System with HAFUSE Technology and the resulting FDA clearance.